Fishers, IN, United States of America

Eric R Diebold

USPTO Granted Patents = 30 


 

Average Co-Inventor Count = 3.7

ph-index = 14

Forward Citations = 2,500(Granted Patents)


Location History:

  • Noblesville, IN (US) (2001 - 2011)
  • Fishers, IN (US) (1993 - 2020)

Company Filing History:


Years Active: 1993-2020

Loading Chart...
Loading Chart...
Loading Chart...
30 patents (USPTO):

Title: **Innovative Contributions of Eric R Diebold in Diabetes Management**

Introduction

Eric R Diebold, located in Fishers, IN, is a prominent inventor known for his substantial contributions to diabetes management technology. With a remarkable portfolio of 30 patents, Diebold has created impactful innovations that enhance the lives of individuals managing diabetes.

Latest Patents

Among his most significant patents, Diebold's inventions include "Methods and systems for analyzing glucose data measured from a person having diabetes". This method involves receiving multiple glucose measurements from a continuous glucose monitoring system and analyzing these values to determine critical glucose thresholds. If certain thresholds are exceeded, alerts are generated on a user interface, aiding in timely insulin administration.

Another notable patent is focused on "Systems and methods for multiple analyte analysis". This invention provides a mechanism to assess different analytes, such as glucose and hydroxybutyrate, in a sample. In this system, an automatic indication related to analyte concentrations is provided, ensuring that users receive essential information regardless of the glucose levels measured.

Career Highlights

Diebold has had a successful career at well-known companies, including Roche Diagnostics Operations, Inc. and Roche Diabetes Care, Inc. Through his tenure at these organizations, Diebold's research and innovation have significantly advanced diabetes care technology.

Collaborations

Throughout his career, Diebold has collaborated with esteemed colleagues such as Nigel A Surridge and Harvey B Buck, Jr. This synergy with other skilled professionals has fostered a collaborative environment that enhances the collective impact of their work in diabetes technology.

Conclusion

Eric R Diebold's innovations have not only contributed to the advancement of diabetes care but have also set a benchmark in the field of medical technology. His patents reflect a dedication to improving patient outcomes, and his ongoing work continues to influence the future of diabetes management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…